Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in “cascade” to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera
Article first published online: 24 APR 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Special Issue: Focus on Analysis of Extracellular Vesicles
Volume 13, Issue 10-11, pages 1701–1713, May 2013
How to Cite
Selvaraju, S. and Rassi, Z. E. (2013), Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in “cascade” to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera. Proteomics, 13: 1701–1713. doi: 10.1002/pmic.201200524
- Issue published online: 3 JUN 2013
- Article first published online: 24 APR 2013
- Accepted manuscript online: 27 MAR 2013 02:59AM EST
- Manuscript Accepted: 12 MAR 2013
- Manuscript Revised: 8 FEB 2013
- Manuscript Received: 19 NOV 2012
- National Institutes of Health. Grant Number: 1R15GM096286–01
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.